Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Garry G. Graham; Kevin D. Pile

doi:10.1007/978-3-7643-8550-7_56

Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Garry G. Graham, Kevin D. Pile

Western Sydney University

Research output: Chapter in Book / Conference Paper › Chapter

Abstract

Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.

Original language	English
Title of host publication	Compendium of Inflammatory Diseases
Editors	Michael J. Parnham
Place of Publication	Switzerland
Publisher	Springer
Pages	1079-1084
Number of pages	6
ISBN (Electronic)	9783764385507
ISBN (Print)	9783764385309
DOIs	https://doi.org/10.1007/978-3-7643-8550-7_56
Publication status	Published - 2016

Keywords

phosphodiesterases
anti-inflammatory agents

Access to Document

10.1007/978-3-7643-8550-7_56

Cite this

@inbook{5006be25ab714aa9b608cc8552104686,

title = "Phosphodiesterase 4 inhibitors : apremilast and roflumilast",

abstract = "Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.",

keywords = "phosphodiesterases, anti-inflammatory agents",

author = "Graham, {Garry G.} and Pile, {Kevin D.}",

year = "2016",

doi = "10.1007/978-3-7643-8550-7_56",

language = "English",

isbn = "9783764385309",

pages = "1079--1084",

editor = "Parnham, {Michael J.}",

booktitle = "Compendium of Inflammatory Diseases",

publisher = "Springer",

}

TY - CHAP

T1 - Phosphodiesterase 4 inhibitors : apremilast and roflumilast

AU - Graham, Garry G.

AU - Pile, Kevin D.

PY - 2016

Y1 - 2016

N2 - Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.

AB - Inhibitors of phosphodiesterase 4 (PDE4) are anti-inflammatory drugs that have been evaluated for the treatment of several inflammatory diseases. The major clinically useful members of this group are apremilast and roflumilast.

KW - phosphodiesterases

KW - anti-inflammatory agents

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:40012

U2 - 10.1007/978-3-7643-8550-7_56

DO - 10.1007/978-3-7643-8550-7_56

M3 - Chapter

SN - 9783764385309

SP - 1079

EP - 1084

BT - Compendium of Inflammatory Diseases

A2 - Parnham, Michael J.

PB - Springer

CY - Switzerland

ER -

Phosphodiesterase 4 inhibitors : apremilast and roflumilast

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this